If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTribal Grp. Regulatory News (TRB)

Share Price Information for Tribal Grp. (TRB)

Share Price is delayed by 15 minutes
Get Live Data
59.00    1.00 (1.72%)
Bid:
57.40
Ask:
59.80
Spread: 2.40 (4.181%)
Market Cap: £126.48m
TRB Live PriceLast checked at - London Stock Exchange

Intraday Tribal Grp. Share Chart

Acquisition

16 Jan 2009 07:00

RNS Number : 7478L
Tribal Group PLC
16 January 2009
Β 

ο»Ώ

Tribal Group plc

Acquisition of Newchurch

Tribal Group plc ("Tribal" or the "Group"),Β theΒ provider of consultancy, support and delivery services to the public sectorΒ in the UKΒ andΒ internationally, is pleased to announce the acquisition ofΒ NewchurchΒ Limited ("Newchurch")Β for a total consideration of up to Β£10.5m.

Newchurch, based in London, is one of the leading health consulting businesses in the UK, providing strategic advice to healthcare organisations at a senior level in both the public and private sectors. Newchurch has established a track record of working with the Department of Health, Strategic Health Authorities and Primary Care Trusts, as well as a number of private providers of healthcare services.

The acquisition ofΒ NewchurchΒ is a further important step in building Tribal's healthcare business, an area expected to benefit from increases in government spending of approximately 5% per annum in the period to 2011.Β 

Newchurch's expertise in commercial and change management will integrate well with Tribal's existing services covering commissioning, finance, informatics, human resources and communications. As a result of the acquisition, Tribal will now be able to offer comprehensive end to end support to healthcare organisations, from strategy and organisational development to front-line change management. Tribal will also be able to support Newchurch's future growth by providing access to key government frameworks. The acquisition of Newchurch should therefore enhance the growth potential of the Group's healthcare interests in the UK.

NewchurchΒ has demonstrated strong growth in recent years. Based onΒ the unaudited management accounts for the year ended 31Β DecemberΒ 2008,Β NewchurchΒ achieved normalised operating profit of Β£1.11m on turnover of Β£3.40mΒ and had gross assets at that date of Β£1.90m.Β Β 

The prospects forΒ NewchurchΒ in 2009 are very encouraging. At the beginning of January, the business hadΒ confirmed projects for 2009Β representingΒ approximatelyΒ 30% of planned revenueΒ for the yearΒ and a strong pipeline ofΒ additionalΒ identified sales opportunities.Β The acquisition is expected to be earnings enhancing in the current financial year to 31 December 2009Β and thereafter.

Newchurch's management team willΒ remain in placeΒ andΒ Kingsley Manning, its Managing Director, will join theΒ senior executiveΒ of Tribal's health business.Β 

Tribal has offered to acquire 100% of the issued share capital ofΒ NewchurchΒ for a total consideration of up to Β£10.5m (the "Offer"). Tribal currently has irrevocable undertakings to accept the OfferΒ from holders of 97%Β of the issued shareΒ capital ofΒ Newchurch.

The total consideration of up to Β£10.5m comprises the following:

up toΒ Β£6.75m in respect of the enterprise value ofΒ Newchurch;
up toΒ Β£0.725m of surplus cash balances to be acquired on completion; and
up to Β£3.0m in respect of carried forward tax losses ("Tax Losses").

The consideration will be paid as follows: 1. On completion,Β up toΒ Β£5.0m (to include an initial payment of Β£0.5m in respect of the Tax Losses) comprising:

a. Β£2.25m in cash;Β  b. up to Β£0.725m in cash forΒ surplus cash;Β and c. the issue ofΒ 2,418,073Β newΒ ordinary shares of 5p each inΒ Tribal ("New Tribal Shares").

2. A payment of up to Β£3.0m, expected to be made on or before 31 March 2009Β andΒ dependent upon confirmation from its audited accounts ofΒ Newchurch's profit for the year ended 31 December 2008,Β comprising: a. up toΒ Β£2.5m in cash; and b. Β£0.5m throughΒ the issue of further New Tribal Shares. 3. DeferredΒ consideration of up to Β£2.5m (to be satisfied by a mix of cash andΒ TribalΒ loan notes) will be paid afterΒ HMRCΒ confirmation of the tax treatment ofΒ the Tax Losses. (TheΒ deferredΒ consideration payable to the vendors will represent two thirds of the future tax benefit realised.)

Completion is expected to beΒ onΒ 27 January 2009.Β FollowingΒ the acquisition ofΒ Newchurch,Β Tribal estimates that its net debt at 31 March 2009 will be approximately Β£22m, against bank facilities, committed to June 2012, of Β£40m.

Application will be made for the admission of the New Tribal Shares to trading on the Main Market of The London Stock Exchange ("Main Market"). Tribal will make a further announcement,Β onceΒ an application is made,Β concerningΒ theΒ dateΒ on whichΒ the New Tribal Shares will commence trading on the Main Market. The New Tribal Shares will rank pari passu in all respects with the existing ordinary shares of 5p each in Tribal.Β 

Commenting on the acquisition ofΒ Newchurch, Peter Martin, Chief Executive of Tribal, said:

"NewchurchΒ is a high quality business run by an excellent management teamΒ and we are delighted thatΒ they haveΒ decided to join Tribal.Β Β Newchurch'sΒ services and client baseΒ complement our healthcareΒ businessΒ andΒ weΒ will now be able to offer our health sector clientsΒ integratedΒ solutions to complexΒ organisational challenges."

Kingsley Manning,Β Managing DirectorΒ ofΒ NewchurchΒ said:

"This is an exciting development forΒ Newchurch.Β Β We share the same values of helping to improve the quality and value for money of essential public services.Β Β As part of Tribal,Β we will have greater access to major contract opportunities and be able to offer our clients a broader range of expertise and services."

Tribal will be releasing its Trading Update in respect of the year ended 31 December 2008 on 28 January 2009 and will be presenting its health business at an investor event to be held on the same date.Β 

Ends

Β 

For further information, please contact:Β 

Β 

Tribal Group plc Telephone: 020 7323 7100Β 

Peter Martin, Chief ExecutiveΒ 

Simon Lawton, Group Finance DirectorΒ 

Β 

Maitland Telephone: 020 7379 5151Β 

Colin BrowneΒ 

Anthony SilvermanΒ 

Β 

Editors' note:Β 

Β 

Tribal provides a range of consultancy, support and delivery services focused on improving the delivery of public services in theΒ UKΒ and internationally. Our core markets are in education, health, housing and regeneration, central government and local government. Tribal employs approximately 2,300 staff and its shares are quoted on the London Stock Exchange (TRB).

In the last set of audited statutory accounts for the year ended December 2007,Β NewchurchΒ delivered turnover of Β£2.1m, EBITDA of Β£0.4m and had gross assets ofΒ Β£0.9m.

Links: Tribal Group plc website: www.tribalgroup.co.ukΒ 

Β 

ThisΒ announcementΒ has been prepared for and is addressed only to our shareholders as a whole and should not be relied on by any other party or for any other purpose. Tribal, its directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom thisΒ announcementΒ is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed.Β 

Β 

ThisΒ announcementΒ may contain forward-looking statements. Any forward-looking statement has been made by the directors in good faith based on the information available to them up to the time of approval of thisΒ announcementΒ and should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying such forward-looking information. To the extent that thisΒ announcementΒ contains any statement dealing with any time after the date of its preparation, such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur and therefore the facts stated and views expressed may change. Tribal undertakes no obligation to update these forward-looking statements.Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQDGGMMRKNGLZM
Date   Source Headline
10th Aug 20217:00 amRNSNotice of Virtual Investor Presentation
5th Aug 20214:35 pmRNSPrice Monitoring Extension
2nd Aug 20217:00 amRNSMultiple Cloud Contract Wins
7th Jul 20217:00 amRNSContract Wins and Notice of Results
1st Jul 202110:54 amRNSTotal Voting Rights
30th Jun 20213:12 pmRNSDirector/PDMR Shareholding
21st Jun 20214:45 pmRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSCapital Markets Day
8th Jun 202112:09 pmRNSBlock listing application
4th Jun 20212:12 pmRNSHolding(s) in Company
1st Jun 20214:41 pmRNSTotal Voting Rights
1st Jun 20217:00 amRNSNotice of Capital Markets Day
4th May 20216:09 pmRNSTotal Voting Rights
4th May 20212:53 pmRNSHolding(s) in Company
4th May 20218:55 amRNSUpdate on acquisition of Semestry Limited
27th Apr 20211:45 pmRNSResult of AGM
27th Apr 20217:00 amRNSAGM Trading Statement
16th Apr 20218:06 amRNSHolding(s) in Company
14th Apr 20214:59 pmRNSDirector/PDMR Shareholding
8th Apr 202112:41 pmRNSHolding(s) in Company
6th Apr 20213:44 pmRNSHolding(s) in Company
6th Apr 20212:09 pmRNSBlock Listing Application
1st Apr 20216:07 pmRNSBlock listing Interim Review
1st Apr 20216:05 pmRNSBlock listing Interim Review
1st Apr 20216:04 pmRNSBlock listing Interim Review
1st Apr 20212:00 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSAcquisition of Semestry Limited
26th Mar 202112:08 pmRNSHolding(s) in Company
18th Mar 20211:32 pmRNSHolding(s) in Company
18th Mar 202112:53 pmRNSTotal Voting Rights
17th Mar 20217:00 amRNSPreliminary Results
9th Mar 20217:00 amRNSAppointment of CFO
11th Feb 20216:00 pmRNSHolding(s) in Company
1st Feb 20217:00 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSTrading Update
21st Jan 20217:00 amRNSBlock Listing Application
14th Jan 20214:41 pmRNSSecond Price Monitoring Extn
14th Jan 20214:36 pmRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSDirector/PDMR Shareholding
31st Dec 202011:16 amRNSKings College London Contract Win
29th Dec 202011:34 amRNSSouth East Asia Contract Win
28th Oct 20201:47 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSTrading Statement
12th Oct 20205:09 pmRNSDebbie Morgan, NCETM Director, receives CBE
6th Oct 20202:31 pmRNSContract Win
28th Aug 20209:33 amRNSCompany Secretary Change
27th Aug 202012:02 pmRNSPrice Monitoring Extension
13th Aug 202011:29 amRNSContract Win
13th Aug 20207:00 amRNSHalf-year Report
6th Aug 20207:00 amRNSNotice of Half Year Results & Conference Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.